Sign In
Buy BCLI
$0.90
-0.0180 (-1.96%)
At Close: Jul 31, 2026
So far Sunday, February 16, NASDAQ is down -2.8% and the S&P is up 0.09%. Let’s take a look at
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL )
77 Biggest Movers From Yesterday
09:59am, Friday, 14'th Feb 2020
Gainers
Revolution Medicines, Inc. (NASDAQ: RVMD) shares surged 70% to close at $28.90 on Thursday. Revolution Medicines priced 14 million share IPO at $17 per share.
BioXcel...
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
01:05pm, Thursday, 13'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N
94 Biggest Movers From Yesterday
10:13am, Wednesday, 12'th Feb 2020
Gainers
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license agreement with Zhejiang HaiChang Biotechnology....
BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn Regulatory Pathway for Approval in ALS
12:00am, Tuesday, 11'th Feb 2020BrainStorm Cell Therapeutics to Announce Fourth Quarter and Full Year —…–9 Financial ...
12:00am, Monday, 10'th Feb 2020BrainStorm CEO to Provide Company Update at the BIO CEO & Investor Conference
12:00am, Tuesday, 04'th Feb 2020BrainStorm Receives Notice of Intention to Grant Additional EU Patent for NurOwn
12:00am, Wednesday, 29'th Jan 2020Investors test share limits at lab outfit ALS
01:00pm, Sunday, 12'th Jan 2020
ALS in testing giant keep rising even as analysts say hold. What's the upside, and downside, risks ahead?
Translate Bio (NASDAQ:TBIO) versus Brainstorm Cell Therapeutics (NASDAQ:BCLI) Head to Head Comparison
07:48am, Saturday, 11'th Jan 2020
Translate Bio (NASDAQ:TBIO) and Brainstorm Cell Therapeutics (NASDAQ:BCLI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the streng
